Disulfide-Crosslinked PGA/HA Membrames for Biomedical Applications

碩士 === 國立陽明大學 === 醫學工程研究所 === 98 === The purpose of this study is to develop a new, mild crosslinking process, to alleviate the toxicity caused by chemical crosslinking and to improve the mechanical property of the synthesized anti-adhesion membrane for surgical operation. In this work, both PGA and...

Full description

Bibliographic Details
Main Authors: Chen-I Lee, 李蓁宜
Other Authors: Ying-Jiin Wang
Format: Others
Language:zh-TW
Published: 2010
Online Access:http://ndltd.ncl.edu.tw/handle/65207496226748129280
id ndltd-TW-098YM005530034
record_format oai_dc
spelling ndltd-TW-098YM0055300342015-10-13T18:49:18Z http://ndltd.ncl.edu.tw/handle/65207496226748129280 Disulfide-Crosslinked PGA/HA Membrames for Biomedical Applications 雙硫鍵交聯聚半乳醣醛酸與透明質酸薄膜在生物醫學上的應用 Chen-I Lee 李蓁宜 碩士 國立陽明大學 醫學工程研究所 98 The purpose of this study is to develop a new, mild crosslinking process, to alleviate the toxicity caused by chemical crosslinking and to improve the mechanical property of the synthesized anti-adhesion membrane for surgical operation. In this work, both PGA and HA molecules were thiolated with cysteine and used as the base macromolecules for constructing three different anti-adhesion membranes (PGA-s-s-PGA, PGA-s-s-HA and HA-s-s-HA). The synthesized PGA-SH and HA-SH contain grafted cysteine of 770 μmol and 330 μmol per gram of polymer, respectively. After coupling with cysteine, thiolated PGA or HA could be crosslinked through disulfide bonds during casting and the membrane thus formed became water-insoluble membranes. Under a wet condition, films of PGA-s-s-PGA and PGA-s-s-HA could be easily manipulated for surgical operation. The three membranes (in the order of PGA-s-s-PGA, PGA-s-s-HA and HA-s-s-HA) have water contents of 43 %, 47 % and 72 %; gel contents of 92 %, 85 % and 81 %; and swelling ratios of 0.77, 0.89 and 2.63 with film thickness increased by 2.44, 1.73 and 2.51 fold, respectively. The results of in-vitro stability and degradation test show that these three films retain 75 % of their initial weight after rinsing in PBS and even treated with 10U of hyaluronidase for over 10 days. These demonstrate that crosslinking by disulfide bonding is an effective way to stabilize the membrane structure. The surfaces of these three films appear to be flat and compact. On the cross sectional area of film, PGA-s-s-PGA exhibits rough textures paralleling with its cross-section plane whereas HA-s-s-HA exhibits flat structure with part of irregular crack patterns, and PGA-s-s-HA displays characteristics of veins of both PGA-s-s-PGA and HA-s-s-HA. The applications of these three films as the carrier for drug delivery were demonstrated by using FITC-labeled BSA as a model compound. The BSA-release data were fitted by a series of models including zero-order, first-order, Higuchi model and the burst effect modification models. Of these, the burst effect modification model (Mt/M∞=Mb/M∞+kt^n) has the highest correlation R-squared value with n values of 0.59, 0.67 and 0.57, and k of 0.0014, 0.0006 and 0.0021, for PGA-s-s-PGA, PGA-s-s-HA and HA-s-s-HA, respectively. It appears that PGA-s-s-HA film has the smallest k value meaning it has the best controlled ability at the initial time to release drugs from the drug carrier. There were some drug retained in films even after incubating for 9 days, but these BSA molecules were not retained covalently by linking to PGA as demonstrated by GPC molecular weight analysis. In summary, we have synthesized PGA-cysteine/HA-cysteine molecules and successfully developed a thiolation crosslinking process for fabricating anti-adhesion membranes based on these two biopolymers. They can be used as an excellent carrier for drug delivery and have a great potential for clinical applications. Ying-Jiin Wang 王盈錦 2010 學位論文 ; thesis 127 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立陽明大學 === 醫學工程研究所 === 98 === The purpose of this study is to develop a new, mild crosslinking process, to alleviate the toxicity caused by chemical crosslinking and to improve the mechanical property of the synthesized anti-adhesion membrane for surgical operation. In this work, both PGA and HA molecules were thiolated with cysteine and used as the base macromolecules for constructing three different anti-adhesion membranes (PGA-s-s-PGA, PGA-s-s-HA and HA-s-s-HA). The synthesized PGA-SH and HA-SH contain grafted cysteine of 770 μmol and 330 μmol per gram of polymer, respectively. After coupling with cysteine, thiolated PGA or HA could be crosslinked through disulfide bonds during casting and the membrane thus formed became water-insoluble membranes. Under a wet condition, films of PGA-s-s-PGA and PGA-s-s-HA could be easily manipulated for surgical operation. The three membranes (in the order of PGA-s-s-PGA, PGA-s-s-HA and HA-s-s-HA) have water contents of 43 %, 47 % and 72 %; gel contents of 92 %, 85 % and 81 %; and swelling ratios of 0.77, 0.89 and 2.63 with film thickness increased by 2.44, 1.73 and 2.51 fold, respectively. The results of in-vitro stability and degradation test show that these three films retain 75 % of their initial weight after rinsing in PBS and even treated with 10U of hyaluronidase for over 10 days. These demonstrate that crosslinking by disulfide bonding is an effective way to stabilize the membrane structure. The surfaces of these three films appear to be flat and compact. On the cross sectional area of film, PGA-s-s-PGA exhibits rough textures paralleling with its cross-section plane whereas HA-s-s-HA exhibits flat structure with part of irregular crack patterns, and PGA-s-s-HA displays characteristics of veins of both PGA-s-s-PGA and HA-s-s-HA. The applications of these three films as the carrier for drug delivery were demonstrated by using FITC-labeled BSA as a model compound. The BSA-release data were fitted by a series of models including zero-order, first-order, Higuchi model and the burst effect modification models. Of these, the burst effect modification model (Mt/M∞=Mb/M∞+kt^n) has the highest correlation R-squared value with n values of 0.59, 0.67 and 0.57, and k of 0.0014, 0.0006 and 0.0021, for PGA-s-s-PGA, PGA-s-s-HA and HA-s-s-HA, respectively. It appears that PGA-s-s-HA film has the smallest k value meaning it has the best controlled ability at the initial time to release drugs from the drug carrier. There were some drug retained in films even after incubating for 9 days, but these BSA molecules were not retained covalently by linking to PGA as demonstrated by GPC molecular weight analysis. In summary, we have synthesized PGA-cysteine/HA-cysteine molecules and successfully developed a thiolation crosslinking process for fabricating anti-adhesion membranes based on these two biopolymers. They can be used as an excellent carrier for drug delivery and have a great potential for clinical applications.
author2 Ying-Jiin Wang
author_facet Ying-Jiin Wang
Chen-I Lee
李蓁宜
author Chen-I Lee
李蓁宜
spellingShingle Chen-I Lee
李蓁宜
Disulfide-Crosslinked PGA/HA Membrames for Biomedical Applications
author_sort Chen-I Lee
title Disulfide-Crosslinked PGA/HA Membrames for Biomedical Applications
title_short Disulfide-Crosslinked PGA/HA Membrames for Biomedical Applications
title_full Disulfide-Crosslinked PGA/HA Membrames for Biomedical Applications
title_fullStr Disulfide-Crosslinked PGA/HA Membrames for Biomedical Applications
title_full_unstemmed Disulfide-Crosslinked PGA/HA Membrames for Biomedical Applications
title_sort disulfide-crosslinked pga/ha membrames for biomedical applications
publishDate 2010
url http://ndltd.ncl.edu.tw/handle/65207496226748129280
work_keys_str_mv AT chenilee disulfidecrosslinkedpgahamembramesforbiomedicalapplications
AT lǐzhēnyí disulfidecrosslinkedpgahamembramesforbiomedicalapplications
AT chenilee shuāngliújiànjiāoliánjùbànrǔtángquánsuānyǔtòumíngzhìsuānbáomózàishēngwùyīxuéshàngdeyīngyòng
AT lǐzhēnyí shuāngliújiànjiāoliánjùbànrǔtángquánsuānyǔtòumíngzhìsuānbáomózàishēngwùyīxuéshàngdeyīngyòng
_version_ 1718037133764067328